NCT00333996终止2 期
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- Allergan
- 入组人数
- 5
- 试验地点
- 1
- 主要终点
- Anterior Chamber Cell
研究概览
简要总结
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye
排除标准
- •Uncontrolled systemic disease
- •Any active ocular infections
结局指标
主要结局
Anterior Chamber Cell
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaDiabetic Macular EdemaNCT00168337Allergan554
已完成
3 期
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionMacular EdemaRetinal Vein OcclusionNCT00168298Allergan668
已完成
3 期
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaDiabetic Macular EdemaNCT00168389Allergan494
已完成
3 期
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionMacular EdemaRetinal Vein OcclusionNCT00168324Allergan599
已完成
2 期
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisIntermediate UveitisPosterior UveitisNCT00333814Allergan229